Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 29 institutions that hold shares in the stock, with a total of 682,296 shares, which have been reported (via 13F filing form) to have a value of $573,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
194,447
shares
|
$163,335
0.0% of portfolio
|
Q2 2025
Reduced 0.04%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
126,603
shares
|
$106,346
0.0% of portfolio
|
Q2 2025
Reduced 8.88%
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
92,087
shares
|
$77,353
7.31% of portfolio
|
Q3 2023
Reduced 66.75%
|
|
|
Equitec Proprietary Markets, LLC
|
Aug 06, 2025 Q2 2025 |
82,727
shares
|
$69,490
0.09% of portfolio
|
Q3 2023
Added 34.7%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
49,800
shares
|
$41,832
0.0% of portfolio
|
Q2 2025
Added 0.61%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
27,606
shares
|
$23,189
0.0% of portfolio
|
Q2 2025
Added 49.98%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
26,200
shares
|
$22,008
0.0% of portfolio
|
Q2 2025
Added 2.75%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
22,592
shares
|
$18,977
0.0% of portfolio
|
Q2 2025
Added 89.59%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
20,299
shares
|
$17,051
0.0% of portfolio
|
Q1 2025
Reduced 24.37%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
19,208
shares
|
$16,134
0.0% of portfolio
|
Q2 2024
Reduced 0.11%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,346
shares
|
$11,210
0.0% of portfolio
|
Q2 2024
Reduced 36.76%
|
|
|
National Bank Of Canada
|
Aug 13, 2025 Q2 2025 |
3,300
shares
|
$2,772
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Aug 14, 2025 Q2 2025 |
2,785
shares
|
$2,339
0.0% of portfolio
|
Q2 2025
Reduced 18.99%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
542
shares
|
$455
0.0% of portfolio
|
Q2 2025
Added 642.47%
|
|
|
Covestor LTD
Boston, MA |
Aug 11, 2025 Q2 2025 |
275
shares
|
$231
0.0% of portfolio
|
Q4 2024
Added 21.68%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Aug 13, 2025 Q2 2025 |
243
shares
|
$204
0.0% of portfolio
|
Q2 2025
Added 2330.0%
|
|
|
Planning Capital Management Corp
Paoli, PA |
Nov 06, 2024 Q3 2024 |
100
shares
|
$84
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
44
shares
|
$36
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Park Square Financial Group, LLC
Roswell, GA |
Aug 12, 2025 Q2 2025 |
37
shares
|
$31
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
16
shares
|
$13
0.0% of portfolio
|
Q1 2025
Reduced 11.11%
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
14
shares
|
$11
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Sachetta, LLC
Lynnfield, MA |
Jul 23, 2025 Q2 2025 |
14
shares
|
$11
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Bfsg, LLC
|
Jul 14, 2025 Q2 2025 |
5
shares
|
$4
0.0% of portfolio
|
Q2 2024
Reduced 28.57%
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Aug 14, 2025 Q2 2025 |
2
shares
|
$1
0.0% of portfolio
|
Q2 2024
Reduced 33.33%
|
|
|
Ifp Advisors, Inc
|
Jul 24, 2025 Q2 2025 |
1
shares
|
$0
0.0% of portfolio
|
Q1 2025
New holding
|